After Roche Walks Away, Atea Puts Break On Late-Stage COVID-19 Oral Antiviral Trial
Atea Pharmaceuticals Inc (NASDAQ: AVIR) said it would
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers
NeuroOne Medical Tech (NASDAQ:NMTC) stock moved upwards by 6.47% to $2.63 during Thursday's after-market session. The company's market cap stands at $41.4 million.
What 5 Analyst Ratings Have To Say About Atea Pharmaceuticals
Over the past 3 months, 5 analysts have published their opinion on Atea Pharmaceuticals (NASDAQ:AVIR) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
SVB Leerink Downgrades Atea Pharmaceuticals to Market Perform, Announces $11 Price Target
SVB Leerink analyst Roanna Ruiz downgrades Atea Pharmaceuticals (NASDAQ:AVIR) from Outperform to Market Perform and announces $11 price target.
61 Biggest Movers From Yesterday
Gainers
Sono Group N.V. (NASDAQ: SEV) shares climbed 154.7% to close at $38.20 on Wednesday after the company priced its IPO at $15 per share.
42 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Sono Group N.V. (NASDAQ: SEV) shares jumped 66% to $24.90 after the company priced its IPO at $15 per share.
Atea Pharmaceuticals Says Strategic Collaboration Pursuant To Which Was Jointly Developing AT-527 For Treatment Of COVID-19 With Roche Will Be Terminating
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) ("Atea"), a clinical-stage biopharmaceutical company, today announced that the strategic collaboration pursuant to which it was jointly developing AT-527 for the
Earnings Scheduled For November 11, 2021
Companies Reporting Before The Bell
• NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million.